Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.44 USD | +2.54% | -1.55% | +4.23% |
Evolution of the average Target Price on Inozyme Pharma, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Inozyme Pharma, Inc.
Jefferies & Co. | |
Wedbush | |
HC Wainwright | |
Needham & Co. |
EPS Revisions
- Stock Market
- Equities
- INZY Stock
- Consensus Inozyme Pharma, Inc.